Overview Financials News + Filings Key Docs Charts Ownership Insiders |
ISC8 INC. (ISCI)
|
Add to portfolio |
|
|
Price: |
$0.10
| | Metrics |
OS: |
256.6
|
M
| |
|
|
Market cap: |
$25.7
|
M
| |
|
|
|
|
| |
|
|
|
|
| | | |
| | | | | |
TTM Valuation | | | |
|
|
| |
|
|
|
|
| |
|
|
EPS |
| |
|
|
BVPS
|
($0.04)
| |
-2.69
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Sep-30-13 | Sep-30-12 | Oct-02-11 | Oct-03-10 | Sep-27-09 | Sep-28-08 | Sep-30-07 | Oct-01-06 |
Revenues | 0.5 | 1.8 | 5.2 | 11.7 | 11.5 | 16.7 | 20.4 | 18.1 |
Revenue growth | -72.2% | -65.2% | -55.8% | 1.6% | -30.8% | -18.2% | 12.8% | -21.6% |
Cost of goods sold | 15.5 | 9.2 | 4.8 | 3.2 | 1.5 | 1.9 | 2.5 | 1.5 |
Gross profit | -15.0 | -7.4 | 0.4 | 8.6 | 10.0 | 14.8 | 17.9 | 16.6 |
Gross margin | -3001.8% | -409.6% | 7.9% | 73.1% | 87.0% | 88.7% | 87.8% | 91.9% |
Selling, general and administrative | 8.8 | 6.8 | 8.1 | | | | | |
Research and development | 8.3 | 6.5 | 3.7 | 2.6 | 2.3 | 1.5 | 1.1 | 0.4 |
General and administrative | 7.8 | 5.1 | 7.9 | 6.6 | 9.6 | 8.9 | 9.2 | 8.2 |
EBIT | -39.7 | -29.9 | -10.6 | -7.3 | 7.0 | -6.4 | -6.0 | -5.5 |
EBIT margin | -7925.1% | -1658.8% | -205.5% | -62.3% | 60.9% | -38.1% | -29.4% | -30.5% |
Pre-tax income | -24.6 | -20.7 | -16.7 | -11.1 | 0.8 | -12.8 | -17.5 | -8.4 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 |
Tax rate | | | 0.0% | | | 0.2% | 0.2% | 0.4% |
Earnings from continuing ops | -27.7 | -27.4 | -15.8 | -11.2 | 0.9 | -12.8 | -17.4 | -8.3 |
Earnings from discontinued ops | -0.3 | 7.7 | | | 0.9 | -8.8 | -4.7 | 0.0 |
Net income | -28.0 | -19.7 | -15.8 | -11.2 | 1.8 | -21.6 | -22.1 | -8.4 |
Net margin | -5593.8% | -1092.1% | -304.4% | -95.2% | 15.4% | -129.3% | -108.6% | -46.2% |
|
Diluted EPS | ($0.17) | ($0.22) | ($0.17) | ($0.62) | $0.05 | ($4.30) | ($7.16) | ($4.25) |
Shares outstanding (diluted) | 163.0 | 123.6 | 90.7 | 18.1 | 16.7 | 3.0 | 2.4 | 2.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|